Day: October 21, 2021

SAN ANTONIO, Oct. 21, 2021 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT), a leading end-to-end multicloud technology solutions company, today announced that it will release its third quarter 2021 financial results after the market closes on Monday, November 15, 2021. Kevin Jones, Chief Executive Officer, and Amar Maletira, President and Chief Financial Officer, will also host a conference call on the day of the release (November 15, 2021) at 5:00 PM ET to discuss the Company’s financial results. Interested parties may access the conference call as follows: Via Zoom:https://rackspace.zoom.us/j/95750453932?pwd=Q21HWis1T1k5UEQvemI2NlFEREp5UT09 Password: 112067 Via telephone (listen only mode): +1 408 638 0968 (US Toll)+1 646 558 8656 (US Toll)+1 647 374 4685 (Canada)+44 (0) 20 3695 0088 (United Kingdom Toll) Webinar ID: 957...

Project Delivery Executive With Significant Experience in Completing Technical Studies for Development Stage ProjectsTORONTO, Oct. 21, 2021 (GLOBE NEWSWIRE) — Ascendant Resources Inc. (TSX: ASND) (FRA: 2D9) (“Ascendant” or the “Company”) is pleased to announce that Clinton Swemmer, has joined as Vice President of Technical Services. Mr. Swemmer will contribute to facilitating the development of the Lagoa Salgada VMS project as it progresses into Feasibility stage. Mr. Swemmer is a senior project delivery professional whose career spans over 20 years working on various development stage projects. Prior to joining Ascendant, Mr. Swemmer held the position of Vice President of Project Delivery for Treasury Metals a mining company where he managed the Study and Trade-Offs to maximize NPV and meet the technical requirements...

Two new executive positions created in connection with departure of R&D Head NEW YORK and DURHAM, N.C., Oct. 21, 2021 (GLOBE NEWSWIRE) — Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company focused on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases, announced today that Gavin Corcoran, M.D., Chief Research and Development Officer, will be leaving the company effective November 12, 2021, to pursue an opportunity with a private healthcare technology company. Pavan Cheruvu, M.D., the Company’s President and Chief Executive Officer (CEO), will assume Dr. Corcoran’s responsibilities as Chief Research and Development Officer going forward. As part of a realignment of the Company’s research and development organization, the Company has established two new executive...

NEW YORK, Oct. 21, 2021 (GLOBE NEWSWIRE) — Hennessy Capital Investment Corp. VI (NASDAQ: HCVIU) (the “Company”) announced today that it closed the sale of an additional 4,092,954 units pursuant to the underwriters’ over-allotment option granted in connection with the Company’s initial public offering (“IPO”). Such over-allotment units were sold at an offering price of $10.00 per unit, generating additional gross proceeds to the Company of approximately $40.9 million and bringing the total gross proceeds of the IPO to approximately $340.9 million. Simultaneously with the closing of the sale of the over-allotment units, the Company completed the private placement and sale of an additional 545,727 private placement warrants at a purchase price of $1.50 per private placement warrant, generating additional gross proceeds to the Company...

HAUPPAUGE, N.Y., Oct. 21, 2021 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the third quarter of 2021 after the close of trading on Thursday, November 4, 2021. The company’s management team will host a corresponding conference call beginning at 4:30 p.m. Eastern Time on November 4, 2021. Investors interested in listening to the conference call may do so by dialing 888-506-0062 from the US or 973-528-0011 from outside the US and providing Entry Code: 938540 or by accessing www.chembio.com/investors/calendar-of-events/. A replay of the call will be available by dialing 877-481-4010 from the US or 919-882-2331 from outside the US using passcode 43155 or by accessing www.chembio.com/investors/calendar-of-events/. About...

New York, NY, Oct. 21, 2021 (GLOBE NEWSWIRE) — Enterprise 4.0 Technology Acquisition Corp. (the “Company”) today announced the closing of its upsized initial public offering of 30,000,000 units, including 3,900,000 units issued pursuant to the partial exercise by the underwriter of its over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $300,000,000.Enterprise 4.0 Technology Acquisition Corp. is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue a business combination target in any business or industry, the Company intends to focus its search on companies in the technology industry. The Company is led by...

NEW YORK, Oct. 21, 2021 (GLOBE NEWSWIRE) — INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the third quarter 2021 on Thursday, November 4, 2021 after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through INNOVATE’s Investor Relations website at www.innovate-ir.com. To listen to the live call, please go to the “Investor Relations” section of the Company’s website at least 15 minutes prior to the start of the call to register and download any necessary audio...

DENVER, Oct. 21, 2021 (GLOBE NEWSWIRE) — StoneCastle Financial Corp. (Nasdaq: BANX) (“StoneCastle” or the “Company”) today announced that it has filed a prospectus supplement with the U.S. Securities and Exchange Commission (“SEC”), under which it may offer and sell up to $30,000,000 of its common stock (the “Common Stock”) from time to time through an “at-the-market” equity offering program (the “ATM Offering”). The Company intends to invest the net proceeds from any sales of its common stock in accordance with its investment policy. The timing and any amount of sales will be determined by a variety of factors determined by the Company. Common Stock will be offered through B. Riley Securities, Inc. (“B. Riley”) which is serving as the sales agent. B. Riley may sell Common Stock by any lawful method deemed to be an “at-the-market...

MINNEAPOLIS, Oct. 21, 2021 (GLOBE NEWSWIRE) — Jamf (NASDAQ: JAMF), the standard in Apple Enterprise Management, announced today that it will report third quarter 2021 financial results for the period ended September 30, 2021 following the close of the market on Thursday, November 11, 2021. On that day, management will host a conference call and webcast at 3:30 p.m. CT (4:30 p.m. ET) to discuss the company’s business and financial results. Jamf Third Quarter 2021 Earnings Conference Call When: Thursday, November 11, 2021 Time: 3:30 p.m. CT (4:30 p.m. ET) Live Call: (833) 519-1319 or (914) 800-3885 Live Webcast: https://ir.jamf.com An archived webcast of the conference call will be accessible on Jamf’s Investor Relations page, https://ir.jamf.com. A telephonic replay of the conference call will be available until Thursday, November...